We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Siolta Therapeutics Stock

Invest in or calculate the value of your shares in Siolta Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Siolta Therapeutics Stock (SIOT)

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

About Siolta Therapeutics Stock

Founded

2016

Headquarters

San Carlos, CA, US

Industries

Science and Engineering, Health Care, Biotechnology

Siolta Therapeutics is a developer of human microbiome therapeutics intended to prevent and treat inflammatory diseases. The company leverages its deep knowledge of the developing gut microbiome and its role in promoting immune tolerance to develop targeted microbial therapeutics and companion diagnostics for the prevention and treatment of inflammatory diseases, enabling medical researchers to harness information from human microbiome studies to design next-generation microbial therapeutics to prevent inflammatory processes.

Siolta Therapeutics Press Mentions

Stay in the know about the latest news on Siolta Therapeutics

Siolta Therapeutics Management

Leadership team at Siolta Therapeutics

Board Member

Eric de la Fortelle

Board Observer

Eric de la Fortelle

Locked Features

Join now and verify your accreditation status to gain access to:

  • Siolta Therapeutics current valuation
  • Siolta Therapeutics stock price
  • Available deals in Siolta Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Siolta Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Siolta Therapeutics through EquityZen funds. These investments are made available by existing Siolta Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Siolta Therapeutics stock?

Shareholders can sell their Siolta Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."